All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
Later on Wednesday the President of the European Commission said the EU was in talks with Pfizer and BionTech for a new contract for 1.8 billion doses, confirming a Reuters report from last week. “We need to focus on technologies that have proven their worth. mRNA vaccines are a clear case in point,” she added.
There are 448 million humans in the EU. Why in heaven’s name would each one of them, regardless of age, need 4 shots in 2022 after they are fully vaccinated this year?
Here in the US, as we approach herd immunity, it looks like approximately half the population does not want these experimental shots, at least not at this time. If the same holds true in Europe, are they planning for 8 shots per person? Or forced vaccinations?
*
Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.
Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]
www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the
copyright owner.
